baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Patient Access Solutions, Inc./ US70324A2087 /

5/21/2024 8:25:35 PM	Chg. -	Volume	Bid-	Ask-	High	Low
0.0000USD	-	969,392 Turnover: .9694	-Bid Size: -	-Ask Size: -	0.0000	0.0000

GlobeNewswire 9:32 AM Curium Extends Irradiation Partnership With NRG I PALLAS in Netherlands for Continuous Supply of Lut...

GlobeNewswire 5/27 Helsinn and Angelini Pharma sign a partnership agreement renewal to commercialize AULIN® and MESULID...

GlobeNewswire 5/16 Fortrea Appoints Machelle Sanders to Board of Directors

GlobeNewswire 5/16 CVRx Announces Key Senior Leadership Team Hires

GlobeNewswire 5/16 ENT and Allergy Associates Reinforces Its Commitment to Future Growth by Welcoming Eight New Special...

GlobeNewswire 5/15 INVO Reports Record First Quarter 2024 Financial Results

GlobeNewswire 5/15 STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire 5/15 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...

GlobeNewswire 5/15 Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results

GlobeNewswire 5/14 Nyxoah Reports First Quarter 2024 Financial and Operating Results

GlobeNewswire 5/14 Versant Diagnostics Announces the Acquisition of Associate Pathologists of Joliet, Ltd. to Advance A...

GlobeNewswire 5/13 Fortrea Reports First Quarter 2024 Results

GlobeNewswire 5/10 Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives

GlobeNewswire 5/10 Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and...

GlobeNewswire 5/9 Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 5/9 Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights

GlobeNewswire 5/9 Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-she...

GlobeNewswire 5/9 Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 5/8 Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements

GlobeNewswire 5/8 Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates

GlobeNewswire 5/8 Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 5/8 Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 st...

GlobeNewswire 5/7 Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...

GlobeNewswire 5/7 Charlesbank Capital Partners Announces the Formation of Kleer-Membersy, Combining the Nation’s Two L...

GlobeNewswire 5/7 Neuronetics Reports Record First Quarter 2024 Financial and Operating Results

Patient Access Solutions, Inc./ US70324A2087 /

If you wish to receive reply to your feedback, please provide your email address.